Financial Gravity Companies’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.53M Buy
+48,030
New +$7.2M 1.22% 24
2025
Q2
$5.35M Buy
+44,198
New +$4.98M 1.05% 23
2024
Q4
$3.72M Buy
38,243
+1,640
+4% +$175K 0.85% 31
2024
Q3
$4.21M Buy
+36,603
New +$4.15M 1.13% 22
2018
Q4
$8K Buy
+106
New +$8.25K 0.01% 632
2018
Q1
$12K Sell
171
-1
-0.6% -$76 0.01% 566
2017
Q4
$14K Buy
+172
New +$13K 0.02% 529

Other funds holding NVS

Financial Gravity Companies's NVS Position: Q2 2026 in Review

Financial Gravity Companies opened a new position in Novartis (NVS) in Q2 2026: 48,030 shares worth $7.53M. The stake represents 1.22% of the portfolio and ranks #24 among its holdings. This is a return to the name: Financial Gravity Companies previously reported a position in NVS as recently as Q2 2025.

Financial Gravity Companies first reported a position in NVS in Q4 2017 and has held it in 7 quarters since. 1,620 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Financial Gravity Companies held 48,030 shares of Novartis worth $7.53M as of Q2 2026.
  • Novartis was a new Financial Gravity Companies position in Q2 2026.
  • Novartis made up 1.22% of Financial Gravity Companies's portfolio in Q2 2026, its #24 holding.
  • Financial Gravity Companies first reported a position in Novartis in Q4 2017 and has held it in 7 quarters since.
  • 1,620 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Financial Gravity Companies's 13F filing for Q2 2026, filed 5 Aug 2026.